What Juvelook is
Juvelook is made by VAIM Co., Ltd. in Korea. The manufacturer classes it as a disposable medical device for temporary improvement of facial wrinkles in adults. It contains poly-D,L-lactic acid, or PDLLA, in non-cross-linked hyaluronic acid. The powder is reconstituted before injection.
The first question is whether your concern is skin quality, volume or laxity. Juvelook may help the first two. It is not a lifting treatment. Dr Sin Yong makes this assessment himself, and he also manages excess Juvelook placed elsewhere.
The two products
Contains 42.5 mg PDLLA and 7.5 mg hyaluronic acid. Used for skin quality, fine lines and texture.
Contains 170 mg PDLLA and 30 mg hyaluronic acid, and is sold internationally as Lenisna. Used for deeper volume and contour.
How Juvelook treatment in Singapore works
The hyaluronic acid gives hydration on the day. The PDLLA then prompts your skin to build its own collagen over the following months. The particles are spherical, partly porous and amorphous, with a mean size of about 30 µm. Sculptra particles are different: sheet-like, about 50 µm and semi-crystalline. Juvelook uses hyaluronic acid as its carrier, while Sculptra uses carboxymethylcellulose. This is why it is described as a collagen stimulator, and why the change arrives slowly.
Who it suits
Concerns about skin quality or fine texture.
Volume concerns where structure is the aim, using Juvelook Volume.
If sagging is your main concern, Juvelook is the wrong tool. The consultation will separate this from a skin-quality or volume concern.
What has been studied
PDLLA has been studied in the nasolabial folds and the tear trough. A 2026 prospective series of 20 patients with nasolabial folds reported improvement at three months, with no nodules or granulomas. A 2025 study in Korean women reported tear trough improvement without severe complications. A 2026 consensus addressed safe injection technique and visual complications for the higher-concentration product. Published follow-up is short, so these findings cannot predict your result. Juvelook can be used under the eyes, yet the clinic prefers energy-based care there: FSX Laser for skin, and the Restore arm of the VF Lift for hollow areas.
Who should avoid it or wait
Pregnancy or breastfeeding, and active infection or inflammation in the area, including an acne flare or cold sore.
Known allergy to a component, or a tendency to keloids or raised scarring.
Earlier filler or collagen stimulator of unknown type, with ultrasound where needed.
Sagging as the main concern, or wanting a fully reversible result.
What Juvelook cannot do
Laxity is a lifting problem and needs a different approach.
Hyaluronidase breaks down the hyaluronic acid carrier, but not the PDLLA.
No randomised trial comparing them has been published.
No duration is promised, and published follow-up is short.
Risks and side effects
Swelling, bruising, tenderness and small bumps at injection points are expected and settle. Nodules can occur with any collagen stimulator. One case report described non-inflammatory tear-trough nodules about three weeks after PDLLA, which resolved with an energy-based device. The serious risk is vascular occlusion, where product enters a blood vessel. The clinic also manages excess Juvelook that was placed elsewhere. If you have had any earlier filler or collagen stimulator, please say so, as it is assessed first.
Warning signs after injection
Call 995 now.
You need urgent assessment by the injecting doctor or at A&E.
See a doctor the same day, or go to A&E if none is available.
Sessions and fees
Session numbers are not published. Placement, dilution and the number of sessions are set after examination. Fees are not published either. They depend on whether the concern is skin quality or volume, the areas treated, dilution and placement, and any earlier filler needing attention first. A written plan with fee factors follows your consultation. Please ask about aftercare at that visit, so that you know what to expect.